2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Liver Steatosis in 4 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Non-alcoholic fatty liver disease (NAFLD) is a common disease associated with metabolic syndrome and can lead to life-threatening complications like hepatic carcinoma and cirrhosis." | 5.48 | Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease. ( Han, C; Li, J; Li, S; Liu, X; Ma, Y; Wang, X; Zhang, J; Zhang, L; Zheng, L, 2018) |
| "Non-alcoholic fatty liver disease (NAFLD) is a common disease associated with metabolic syndrome and can lead to life-threatening complications like hepatic carcinoma and cirrhosis." | 1.48 | Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease. ( Han, C; Li, J; Li, S; Liu, X; Ma, Y; Wang, X; Zhang, J; Zhang, L; Zheng, L, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, S | 2 |
| Wang, X | 1 |
| Zhang, J | 1 |
| Li, J | 1 |
| Liu, X | 1 |
| Ma, Y | 1 |
| Han, C | 1 |
| Zhang, L | 1 |
| Zheng, L | 1 |
| Yang, L | 1 |
| Han, Z | 1 |
| Tian, L | 1 |
| Mai, P | 1 |
| Zhang, Y | 1 |
| Wang, L | 1 |
| Li, L | 1 |
| Ogawa, W | 1 |
| Emi, A | 1 |
| Hayashi, K | 1 |
| Senga, Y | 1 |
| Nomura, K | 1 |
| Hara, K | 1 |
| Yu, D | 1 |
| Kasuga, M | 1 |
| Kohli, R | 1 |
| Pan, X | 1 |
| Malladi, P | 1 |
| Wainwright, MS | 1 |
| Whitington, PF | 1 |
4 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Liver Steatosis
| Article | Year |
|---|---|
Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Blood Glucose; Body Weight; Chromones; Diet, | 2018 |
Sphingosine 1-Phosphate Receptor 2 and 3 Mediate Bone Marrow-Derived Monocyte/Macrophage Motility in Cholestatic Liver Injury in Mice.
Topics: Animals; Bone Marrow Cells; Cell Movement; Cells, Cultured; Chemokines; Chromones; Cytokines; Enzyme | 2015 |
Role of S6K1 in regulation of SREBP1c expression in the liver.
Topics: Animals; Cell Line; Chromones; Fatty Liver; Gene Expression Regulation; Hepatocytes; Hypertriglyceri | 2011 |
Mitochondrial reactive oxygen species signal hepatocyte steatosis by regulating the phosphatidylinositol 3-kinase cell survival pathway.
Topics: Animals; Apoptosis; Cell Survival; Chromones; Fatty Acids, Nonesterified; Fatty Liver; Gene Expressi | 2007 |